project id: TCGA-KIRP; case submitter id: TCGA-B1-A656; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 2.1; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.05; rna integrity number: 7.0; age at index: 64; days to birth: -23702; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 23702; ajcc clinical m: M0; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 618.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 210; initial weight: 80.0; sample id: 7e6f9d8d-5e6e-40b1-a674-76f34efa63d1; sample submitter id: TCGA-B1-A656-01A; portion id: 59376aed-450e-4226-850d-e95b53c178d0; portion submitter id: TCGA-B1-A656-01A-11; slide id: 184a92a6-67fd-41e9-b7fb-1b717437af3d; slide submitter id: TCGA-B1-A656-01A-01-TS1; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; section location: TOP;